igf-1 lr3 muscle growth risks Peptide Therapy Chicago What is IGF-1 LR3? Insulin-Like
Description
doi: 10.1016/j.toxrep.2024.101708, 190
A Phase 2 study published in the New England Journal of Medicine in 2023 (Jastreboff et al.) reported substantial weight loss in participants with obesity
1 , e004093 (2012)
First characterized by Lee et al
